North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorColumbia University

About this trial

The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patients diagnosed with or suspected to have a mitochondrial disorder

Adult carriers of known mitochondrial DNA mutations

Patients with laboratory analysis indicative of a mitochondrial disorder.

Medical information and tissue samples are also accepted from deceased individuals who fulfill the above criteria.

Disqualifiers

Patients not suspected of having a mitochondrial disorder

Patients not suspected of carrying a mitochondrial DNA or nuclear DNA mutation that affects mitochondrial function.

Trial population

Patients with known mitochondrial disorders. People at risk of carrying a mitochondrial DNA mutation Patients with abnormal mitochondrial function

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

1,000 Participants
are grouped into 1 trial group
Group A: Mitochondrial Disease Patients

Trial outcomes

Primary outcomes

1

There is no primary outcome measure for this study

This is a registry protocol and therefore there is no primary outcome measure for this study.

Time frame
end of study

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Columbia University

Lead sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborator